Marinomed Biotech AG (FRA:93Z)

Germany flag Germany · Delayed Price · Currency is EUR
12.80
-0.20 (-1.54%)
Last updated: Apr 24, 2026, 8:05 AM CET
Market Cap25.21M +2.0%
Revenue (ttm)27.15M +460.3%
Net Income18.02M
EPSn/a
Shares Outn/a
PE Ratio1.40
Forward PE9.17
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume55
Open12.80
Previous Close13.00
Day's Range12.80 - 12.80
52-Week Range11.25 - 21.10
Betan/a
RSI41.99
Earnings DateApr 22, 2026

About Marinomed Biotech AG

Marinomed Biotech AG, a biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally. It operates through Virology, Immunology, and Other segments. The company’s products pipeline includes Budesolv for the treatment of allergic rhinitis; Tacrosolv, which is in Phase II clinical trial for inflammatory eye diseases; and Inhaleen for viral infection of the upper and lower respiratory tract. It also provides Solv4U which offers formulation development a... [Read more]

Industry Pharmaceutical Preparations
Founded 2006
Employees 33
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 93Z

Financial Performance

Financial Statements